| Page 1313 | Kisaco Research

Practical insights on how to prepare and manage cross-border investigation and remediation process in the face of rapidly multiplying and overlapping risks


• How are investigations initiated by authorities in key jurisdictions?
• Gathering evidence: Legal privilege, data privacy laws and disclosure actions
• What do enforcement agencies and regulatory bodies require in respect of historic conduct and what will be considered as mitigating factors?
• Making a case for remediation: Decisive factors, procedural and law enforcement nuisances

Virtual Session
 

Jerry Zeldis

Executive Vice President, Research and Development
NexImmune

Jerry Zeldis

Executive Vice President, Research and Development
NexImmune

Jerry Zeldis

Executive Vice President, Research and Development
NexImmune
 

Shiara Mutukisna

Head of Legal and Compliance and Data Privacy Officer
Roche Diagnostics APAC

Shiara Mutukisna is Head of Legal and Compliance and Data Privacy Officer, for Roche Diagnostics APAC. She has over 20 years experience in leading Legal, Compliance and Risk functions of global organizations across the APAC region, in the  Pharmaceutical, and Medical Devices industries. Shiara has built compliance programs from the ground up, including developing the organizational infrastructure of the function and the individual skill development of compliance professionals.

Shiara Mutukisna

Head of Legal and Compliance and Data Privacy Officer
Roche Diagnostics APAC

Shiara Mutukisna

Head of Legal and Compliance and Data Privacy Officer
Roche Diagnostics APAC

Shiara Mutukisna is Head of Legal and Compliance and Data Privacy Officer, for Roche Diagnostics APAC. She has over 20 years experience in leading Legal, Compliance and Risk functions of global organizations across the APAC region, in the  Pharmaceutical, and Medical Devices industries. Shiara has built compliance programs from the ground up, including developing the organizational infrastructure of the function and the individual skill development of compliance professionals. Shiara has created and managed local and regional corporate compliance programs and initiated projects including performing complex investigations, and other structural elements of a Corporate Compliance Program. Shiara is also a Privacy expert, who advises on European and APAC privacy regulations.

 

Dr. Chandni Bhan

UK Head of Risk
Morgan Stanley

Dr. Chandni Bhan is Global Head of quant research and Model Risk, and Head of risk for UK for Morgan Stanley Investment Management. Previously she held roles across the business as head of risk for MSIM EMEA, as well CRO for MSIM Ireland. She has more than 16 years of working in Finance, both in front office, as well as risk, with extensive buy side and sell side expertise.

Dr. Chandni Bhan

UK Head of Risk
Morgan Stanley

Dr. Chandni Bhan

UK Head of Risk
Morgan Stanley

Dr. Chandni Bhan is Global Head of quant research and Model Risk, and Head of risk for UK for Morgan Stanley Investment Management. Previously she held roles across the business as head of risk for MSIM EMEA, as well CRO for MSIM Ireland. She has more than 16 years of working in Finance, both in front office, as well as risk, with extensive buy side and sell side expertise. She earned her PhD in statistics & probability from Michigan State University, and as an experienced  data scientist and risk officer, she has pioneered analytical systems to build a proactive and forward looking risk function, embedded in the business, that ensures we drive risk prudent growth for our clients. She is a member of EMEA operating committee, risk leadership group, and several other committees globally including as the chair for the global investment management model risk committee.  She also hosts several diversity podcasts and webinars for the business and is passionate about building a culture of inclusion and innovation.

Interview: Dionys Forster
 

Tina Sarén

Senior Scientist
Elicera Therapeutics

Tina Sarén

Senior Scientist
Elicera Therapeutics

Tina Sarén

Senior Scientist
Elicera Therapeutics